This report aims to provide an outlook on the current state of the electroceuticals market and the business issues that will determine the future viability of this market. It also focuses on the latest research trends at home and abroad, and suggests strategic directions that can be explored in the domestic healthcare business environment.
Table of Contents
Abbreviations and AcronymsDisclaimer
Preface
1 Overview
1.1 Definition of Electroceuticals
1.2 Electroceuticals vs. Digital Therapeutics
1.3 Scope of Research
2 Understanding Electroceuticals Technology
2.1 Understanding TMS
2.1.1 Clinical Evidence Development
2.1.2 Treatment Process of rTMS
2.1.3 Latest Technology Trends
2.2 Understanding tDCS
2.2.1 Clinical Evidence Development
2.2.2 Treatment Process of tDCS
3 Current Market of Electroceuticals
3.1 Current Market of Korea
3.1.1 Major Suppliers
3.1.2 Electroceuticals and NHIS
3.1.3 Clinical Trials Approved in Korea
3.2 Global Electroceuticals Market
3.2.1 Major Suppliers
3.2.2 Global Clinical Trials on Electroceuticals
3.2.3 Global Electroceuticals Research & Development
4 Demand Forecast for Electroceuticals
4.1 Electroceuticals by Indication
4.1.1 Depression
4.1.2 Anxiety Disorder
4.1.3 Insomnia
4.1.4 Obsessive-Compulsive Disorder
4.1.5 Addiction
4.2 Market Size of Pharmaceuticals to Electroceuticals’ Indications
4.3 Market Drivers and Market Restraints
4.3.1 Market Drivers
4.3.2 Market Restraints
5 Business Strategy Suggestions
5.1 Korean Market Access Strategy
5.2 Global Market Access Strategy
5.3 Conclusion
- Appendix 1 Detailed Target Disease Codes
- Appendix 2 Non-Reimbursement TMS Charges
- Appendix 3 TMS Device FDA Approval Status
Companies Mentioned
- Remed
- NuEyne
- Ybrain
- Neurophet
- Brainsway
- Neuronetics
- Magstim
- Magventure
Methodology
LOADING...